The following six biosimilars were given a positive opinion at the June meeting: treatments for treatment of age-related macular degeneration and visual impairment: Mynzepli (aflibercept), and its ...

The American Society for Transplantation and Cellular Therapy is proud to announce the release of a refreshed Practice ...

A team of surgeons led by Paediatric Haematologist Oncologist S. Abhilasha successfully conducted a bone marrow transplant on ...

In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...

Introduction A major driver of the global autologous cell therapy market is the rising demand for personalized and precision-based medical trea ...

During the early days of research on bone marrow transplants, the procedure was difficult for patients to endure and had a ...

Tabelecleucel shows promising efficacy in treating EBV-positive PTLD, offering hope for patients resistant to previous ...

VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and anthracycline ...

Many countries lack blood donors. The quest to create an artificial, lab-made blood type that could make up for supply ...

Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market ...

HSPCs polarize in contact with bone marrow stromal cells constituting their niche. This study analyses the polarity of ...

Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using CRISPR-Cas9 in combination with AAV6 vectors can trigger inflammatory and ...